Exelixis Inc (EXEL) stock analysis and AI prediction
The company facts of Exelixis Inc, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Exelixis Inc
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $17.0 billion
- Size
- Large cap
- Employees
- 1,077
- Headquarters
- ALAMEDA, CA
- Listed since
- April 11, 2000
- Website
- exelixis.com
More Healthcare stocks
Other large cap stocks
Keep going
EXEL questions
What is the AI prediction for EXEL stock?
Each market day our model rates Exelixis Inc (EXEL) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the EXEL prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for EXEL?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see EXEL options?
The EXEL options page opens its calls and puts, with price, volume, implied volatility and the Greeks.